Optimal management of asymptomatic carotid stenosis in 2021: the jury is still out. An international, multispecialty, expert review and position statement

K.I. Paraskevas*, D.P. Mikhailidis, P.L. Antignani, H. Baradaran, R.P.H. Bokkers, R.P. Cambria, A. Dardik, A.H. Davies, H.H. Eckstein, G. Faggioli, J.F.E. Fernandes, G. Fraedrich, G. Geroulakos, P. Gloviczki, J. Golledge, A. Gupta, M.K. Jezovnik, S.K. Kakkos, N. Katsiki, M. KnoflachM.E. Kooi, G. Lanza, C.D. Liapis, I.M. Loftus, A. Mansilha, A. Millon, A.N. Nicolaides, R. Pini, P. Poredos, J.B. Ricco, T.S. Riles, P.A. Ringleb, T. Rundek, L. Saba, F. Schlachetzki, M. Silvestrini, F. Spinelli, F. Stilo, S. Sultan, J.S. Suri, C.J. Zeebregts, S. Chaturvedi

*Corresponding author for this work

Research output: Contribution to journal(Systematic) Review article peer-review

2 Downloads (Pure)

Abstract

The recommendations of international guidelines for the management of asymptomatic carotid stenosis (ACS) often vary considerably and extend from a conservative approach with risk factor modification and best medical treatment (BMT) alone, to a more aggressive approach with a carotid intervention plus BMT. The aim of the current multispecialty position statement was to reconcile the conflicting views on the topic. A literature review was performed with a focus on data from recent studies. Several clinical and imaging high-risk features have been identified that are associated with an increased long-term ipsilateral ischemic stroke risk in patients with ACS. Such high-risk clinical/imaging features include intraplaque hemorrhage, impaired cerebrovascular reserve, carotid plaque echolucency/ulceration/ neovascularization, a lipid-rich necrotic core, a thin or ruptured fibrous cap, silent brain infarction, a contralateral transient ischemic attack/stroke episode, male patients <75 years and microembolic signals on transcranial Doppler. There is growing evidence that 80-99% ACS indicate a higher stroke risk than 50-79% stenoses. Although aggressive risk factor control and BMT should be implemented in all ACS patients, several high-risk features that may increase the risk of a future cerebrovascular event are now documented. Consequently, some guidelines recommend a prophylactic carotid intervention in high risk patients to prevent future cerebrovascular events. Until the results of the much-anticipated randomized controlled trials emerge, the jury is still out regarding the optimal management of ACS patients. (Cite this article as: Paraskevas KI, Mikhailidis DP, Antignani PL, Baradaran H, Bokkers RP, Cambria RP, et al. Optimal management of asymptomatic carotid stenosis in 2021: the jury is still out. An international, multispecialty, expert review and position statement. Int Angiol 2022;41:158-69. DOI: 10.23736/S03929590.21.04825-2)
Original languageEnglish
Pages (from-to)158-169
Number of pages12
JournalInternational Angiology
Volume41
Issue number2
DOIs
Publication statusPublished - 1 Apr 2022

Keywords

  • Carotid stenosis
  • Stroke
  • Endarterectomy
  • carotid
  • HEALTH-CARE PROFESSIONALS
  • CEREBRAL HEMODYNAMICS
  • PRIMARY PREVENTION
  • STROKE PREVENTION
  • MEDICAL-TREATMENT
  • ISCHEMIC-STROKE
  • GUIDELINES
  • ENDARTERECTOMY
  • ASSOCIATION
  • RECURRENCE

Cite this